Park Ha Biological Technology Co
BYAH
2 hedge funds and large institutions have $101 invested in Park Ha Biological Technology Co in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
80% less funds holding
Funds holding: 10 → 2 (-8)
100% less capital invested
Capital invested by funds: $107K → $101 (-$107K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$54.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$14.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$11.8K |
| 4 |
VF
Virtu Financial
New York
|
-$11K |
| 5 |
Jane Street
New York
|
-$5.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $84 | +$31 | +1 | +11% |
|
2
Morgan Stanley
New York
| $17 | -$437 | -14 | -88% |
|
|
3
Renaissance Technologies
New York
| – | -$54.2K | -852 | Closed |
|
|
4
Citadel Advisors
Miami,
Florida
| – | -$14.9K | -235 | Closed |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| – | -$11.8K | -185 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$11K | -178 | Closed |
|
|
7
Jane Street
New York
| – | -$5.92K | -93 | Closed |
|
8
Geode Capital Management
Boston,
Massachusetts
| – | -$2.68K | -42 | Closed |
|
|
SG
9
StoneX Group
New York
| – | -$2.54K | -40 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$2.52K | -40 | Closed |
|
BYAH Hedge Fund Activity: Q1 2026 in Review
2 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q1 2026, worth a combined $101 — down 100% from $107K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of BYAH and 0 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $31. The largest seller was Renaissance Technologies, exiting entirely with an estimated $54.2K sold.
- 2 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q1 2026, down from 10 in Q4 2025.
- Funds reported $101 of Park Ha Biological Technology Co stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Park Ha Biological Technology Co positions in Q1 2026 and 8 closed out, a net change of -8 holders.
- The largest Park Ha Biological Technology Co buyer in Q1 2026 was UBS Group, an estimated $31 added.
- The largest Park Ha Biological Technology Co seller in Q1 2026 was Renaissance Technologies, an estimated $54.2K sold.
Based on aggregated 13F filings for Q1 2026.